Cytosorbents (CTSO) Reports FY18 Loss of $0.56
Tweet
Share
E-mailGet Alerts CTSO Hot Sheet
Join SI Premium – FREE
Cytosorbents (NASDAQ: CTSO) reported Q4 FY18 of ($0.56), versus ($0.32) reported last year. Revenue for the year came in at $22.5 million, versus $15.15 million reported last year.
For earnings history and earnings-related data on Cytosorbents (CTSO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Royal Caribbean to acquire 50% stake in Sandals Resorts for $3 billion
- CytoSorbents regains Nasdaq minimum bid price compliance
- Surf Air Mobility names Palantir veteran as president of SurfOS
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
